San Diego-based mostly Viking Therapeutics marked itself as a serious competitor inside the weight loss drug marketplace in February immediately after revealing promising info from the mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when specified as being a weekly injection As well a